Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1696 AL 1710

Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism

Chen HH, Lin SC, Chan MH.

Neurodegener Dis. 2011;8(5):364-74. doi: 10.1159/000323872. Epub 2011 Apr 15.

Cancer and Parkinson's disease: the odd couple

Gao X, Ning Y.

Drugs Today (Barc). 2011 Mar;47(3):215-22. doi: 10.1358/dot.2011.47.3.1519657.

Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?

Clarke CE, Patel S, Ives N, Rick C, Wheatley K, Gray R.

Mov Disord. 2011 Jun;26(7):1187-93. doi: 10.1002/mds.23519. Epub 2011 Apr 14.

Parkinsonism and dystonia associated with adalimumab

Ha AD, Jankovic J.

Mov Disord. 2011 Jul;26(8):1556-8. doi: 10.1002/mds.23548. Epub 2011 Apr 14.

"Silly walks" in Parkinson's disease: unusual presentation of dopaminergic-induced dyskinesias

Růžička E, Zárubová K, Nutt JG, Bloem BR.

Mov Disord. 2011 Aug 1;26(9):1782-4. doi: 10.1002/mds.23667. Epub 2011 Apr 14.

The omega-class glutathione transferases: structure, function, and genetics

Board PG.

Drug Metab Rev. 2011 May;43(2):226-35. doi: 10.3109/03602532.2011.561353.

Human embryonic stem cell therapies for neurodegenerative diseases

Tomaskovic-Crook E, Crook JM.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):440-8. doi: 10.2174/187152711795564001.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. doi: 10.2174/187152711795563994.

Molecular manipulation targeting regulation of dopaminergic differentiation and proliferation of neural stem cells or pluripotent stem cells

Ding YX, Wei LC, Wang YZ, Cao R, Wang X, Chen LW.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):517-28. doi: 10.2174/187152711795563912.

Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells

Zhao J, Xu Q.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):509-16. doi: 10.2174/187152711795563921.

Electrovectorcardiographic diagnosis of left septal fascicular block: anatomic and clinical considerations

Pérez Riera AR, Ferreira C, Ferreira Filho C, Meneghini A, Uchida AH, Moffa PJ, Schapachnik E, Dubner S, Baranchuk A.

Ann Noninvasive Electrocardiol. 2011 Apr;16(2):196-207. doi: 10.1111/j.1542-474X.2011.00416.x.

Huntington's disease - neuropathology

Vonsattel JP, Keller C, Cortes Ramirez EP.

Handb Clin Neurol. 2011;100:83-100. doi: 10.1016/B978-0-444-52014-2.00004-5.

Orthostatic tremor - a review

Gerschlager W, Brown P.

Handb Clin Neurol. 2011;100:457-62. doi: 10.1016/B978-0-444-52014-2.00035-5.

Dopa-responsive dystonia

Segawa M.

Handb Clin Neurol. 2011;100:539-57. doi: 10.1016/B978-0-444-52014-2.00039-2.

Rapid-onset dystonia-parkinsonism

Geyer HL, Bressman SB.

Handb Clin Neurol. 2011;100:559-62. doi: 10.1016/B978-0-444-52014-2.00040-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias